Talis Biomedical Corporation Share Price
Equities
TLIS
US87424L2079
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.14 USD | +1.56% | +2.70% | +22.68% |
02/04 | North American Morning Briefing : Stocks Seen -2- | DJ |
28/03 | Talis Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 4.81M 401M | Sales 2023 | 2.13M 178M | Capitalization | 13.57M 1.13B |
---|---|---|---|---|---|
Net income 2022 | -113M -9.42B | Net income 2023 | -62M -5.17B | EV / Sales 2022 | -17.6 x |
Net cash position 2022 | 96.61M 8.06B | Net cash position 2023 | 57.06M 4.76B | EV / Sales 2023 | -20.4 x |
P/E ratio 2022 |
-0.11
x | P/E ratio 2023 |
-0.22
x | Employees | 99 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 91.69% |
Latest transcript on Talis Biomedical Corporation
1 day | +1.56% | ||
1 week | +2.70% | ||
Current month | +4.46% | ||
1 month | +1.56% | ||
3 months | +16.14% | ||
6 months | +97.46% | ||
Current year | +22.68% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Kelley
CEO | Chief Executive Officer | 52 | 01/20/01 |
Director of Finance/CFO | 51 | 01/22/01 | |
Kim Popovits
BRD | Director/Board Member | 65 | 31/20/31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Matthew Posard
BRD | Director/Board Member | 56 | 01/16/01 |
Randal Scott
BRD | Director/Board Member | 66 | 01/14/01 |
Kim Popovits
BRD | Director/Board Member | 65 | 31/20/31 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 9.14 | +1.56% | 4,549 |
25/24/25 | 9 | -2.18% | 3,730 |
24/24/24 | 9.2 | +2.11% | 3,352 |
23/24/23 | 9.01 | +0.11% | 8,738 |
22/24/22 | 9 | +1.12% | 9,727 |
Delayed Quote Nasdaq, April 27, 2024 at 02:00 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
+22.68% | 16.65M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- TLIS Stock